PMID- 22475522 OWN - NLM STAT- MEDLINE DCOM- 20120716 LR - 20220317 IS - 1879-0038 (Electronic) IS - 0378-1119 (Linking) VI - 500 IP - 1 DP - 2012 May 25 TI - Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy. PG - 1-9 LID - 10.1016/j.gene.2012.03.056 [doi] AB - A meta-analysis was performed to assess the associations of the receptor for advanced glycation end products (RAGE) gene polymorphisms [Gly82Ser (rs2070600), 1704G/T (rs184003), 429T/C (rs1800625)] with type 2 diabetes mellitus (T2DM), diabetic retinopathy (DR) and diabetic nephropathy (DN). A comprehensive research was conducted to identify all case-control or cohort studies. The fixed or random effect pooled measure was selected based on the homogeneity test among studies that was evaluated with I(2). Meta-regression was used to explore the potential sources of between-study heterogeneity. Publication bias was estimated using Peters test. Twenty-nine articles were included. Overall, after excluding articles deviating from Hardy-Weinberg equilibrium in controls and sensitive analysis, no significant association was found between RAGE gene polymorphisms (Gly82Ser, 1704G/T, 429T/C) and any of T2DM, DR and DN risk, respectively. Subgroup analysis stratified by ethnicity (Asian and Caucasian) also found no significant association between the above-mentioned three polymorphisms and T2DM risk, respectively. This meta-analysis suggested that there might be no association of RAGE gene polymorphisms (Gly82Ser, 1704G/T, 429T/C) with T2DM, DR and DN risk. CI - Copyright (c) 2012 Elsevier B.V. All rights reserved. FAU - Kang, Peipei AU - Kang P AD - Department of Epidemiology and Health Statistics, Shandong University, People's Republic of China. FAU - Tian, Changwei AU - Tian C FAU - Jia, Chongqi AU - Jia C LA - eng PT - Journal Article PT - Meta-Analysis PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20120323 PL - Netherlands TA - Gene JT - Gene JID - 7706761 RN - 0 (Receptor for Advanced Glycation End Products) RN - 0 (Receptors, Immunologic) SB - IM MH - Amino Acid Substitution MH - Diabetes Mellitus, Type 2/ethnology/*genetics MH - Diabetic Nephropathies/ethnology/*genetics MH - Diabetic Retinopathy/ethnology/*genetics MH - Humans MH - *Polymorphism, Genetic MH - Receptor for Advanced Glycation End Products MH - Receptors, Immunologic/*genetics EDAT- 2012/04/06 06:00 MHDA- 2012/07/17 06:00 CRDT- 2012/04/06 06:00 PHST- 2011/11/04 00:00 [received] PHST- 2012/03/15 00:00 [revised] PHST- 2012/03/15 00:00 [accepted] PHST- 2012/04/06 06:00 [entrez] PHST- 2012/04/06 06:00 [pubmed] PHST- 2012/07/17 06:00 [medline] AID - S0378-1119(12)00368-X [pii] AID - 10.1016/j.gene.2012.03.056 [doi] PST - ppublish SO - Gene. 2012 May 25;500(1):1-9. doi: 10.1016/j.gene.2012.03.056. Epub 2012 Mar 23.